A route to the organometallic complex 8 is described, along with a study of its antiproliferative effects on breast cancer cell lines; in the examples studied, 8 behaves in a very similar manner to tamoxifen, suggesting new possibilities for applications in organometallic chemistry.
Tamoxifen 1 and its active metabolite, 4-hydroxytamoxifen 2 (Scheme 1) have been the subject of numerous studies owing to their efficacy in breast cancer treatment.
1,2 Currently however, substitutes are being sought in order to obviate the effects of resistance build up, as well as to improve the therapeutic effectiveness of the current treatments. 3,4 Our study is an attempt to potentiate the effects of these medications by introducing an organometallic-type modification to the base skeleton. and for the individual isomers Z and E on the two oestrogen receptor subtypes ERα and ERβ using a competitive radiometric binding assay, with tritium-labeled oestradiol as tracer and protamine sulfate precipitation of the bound fraction of the tracer. 13 ERα was prepared from sheep uterus and ERβ, expressed in baculovirus, was obtained commercially from PanVera.
The RBA values (mean of 2 or 3 experiments) found at 0 °C for 8 on ERα are 8% for the mixture 8 (Z + E), 7.4% for 8Z and 5.2% for 8E, thus showing only a slight difference between the two isomers. In contrast, the RBA value obtained for ERβ is higher with 8Z (17.8%) than for the mixture 8 (Z + E) (6%) or the E isomer 8E (5.6%). However it is important to notice that ERβ is a purified receptor devoid of the effectors naturally present in the receptor alpha preparation obtained from sheep. Nevertheless the affinity for both ERα and ERβ are still satisfactory even if these RBA values are lower than the values found for 2 (Z + E) on ERα (38.5%) and ERβ (20%). This decrease probably reflects the greater steric crowding of (η 5 -C5H4)Re(CO)3 in 8 relative to the phenyl group in 2.
We studied the agonist-antagonist effect of compound 8 (Z + E) on cell lines derived from breast cancer tumours (MVLN, MDA-MB231) ( Table) . On MDA-MB231 cells which do not possess ERα but may possess ERβ, 15 8 and 2 have no effect. It thus appears that the observed antiproliferative effect is dependent on the oestradiol receptor α, as is also the case with tamoxifen. 
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Cell It appears that 8 may have a higher potential as an organometallic radiopharmaceutical, despite the fact that up to now the chelate route has been the one explored with tamoxifen; 17 in the latter case the ER binding rate was found to be too small to measure, which was not the case with 8. It is therefore important to find a rapid route by which to attach useful isotopes of Tc and Re to 8. To this end, we plan to use a selective photochemical decomplexation reaction that we have recently discovered, followed by rapid 
